Mark D. Smith - 02 Dec 2022 Form 4 Insider Report for Jazz Pharmaceuticals plc (JAZZ)

Role
Director
Signature
By: /s/Adam Guttmann, as attorney in fact For: Mark D. Smith
Issuer symbol
JAZZ
Transactions as of
02 Dec 2022
Transactions value $
-$64,966
Form type
4
Filing time
06 Dec 2022, 17:57:15 UTC
Previous filing
09 Aug 2022
Next filing
05 Apr 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction JAZZ Ordinary Shares Sale -$65K -420 -7.13% $154.68 5.47K 02 Dec 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units.